PTGX Protagonist Therapeutics Inc

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.

$30.12  -0.85 (-2.75%)
As of 10/18/2021 15:59:50 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/11/2016
Outstanding shares:  47,550,573
Average volume:  4,593,593
Market cap:   $1,483,102,372
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74366E102
ISIN:        US74366E1029
Valuation   (See tab for details)
PE ratio:   -18.07
PB ratio:   4.12
PS ratio:   54.49
Return on equity:   -22.80%
Net income %:   -299.39%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy